Chane-Du described ADG126 as a “next generation masked conditional CTLA-4 antagonist” and said the program is differentiated on three fronts. First, he said Adagene’s CTLA-4 antibody binds a different ...

In a study published in Angewandte Chemie International Edition , a team led by Profs. BAO Xinhe, GAO Dunfeng, and ZHANG Guohui from the Dalian ...

Inform future clinical development plans, further establishing elraglusib as a potential backbone therapy in ...

The cGAS-STING signaling pathway has emerged as a major focus in cancer immunotherapy because it stimulates interferon production and enhances antitumor immune responses. However, despite strong ...

Rising NEC Incidence: The global increase in diagnosed cases of neuroendocrine tumors (including carcinomas) is a major market growth driver. This uptick is driven by better detection and reporting, ...

Cancer immunotherapies often rely on activating immune responses, yet many tumors remain resistant because their internal survival mechanisms are ...

The healing of the spinal cord depends on carefully timed interactions between injured nerve cells and their surrounding environment, according to a study published in Science Advances by researchers ...

Researchers uncover how distinct cell populations and fibrotic signals drive permanent scarring after rotator cuff ...

Closing of additional $50 million tranche of $100 million equity private placement after achievement of clinical milestone for rondecabtagene ...

Nanjing Leads Biolabs Co., Ltd. ('Leads Biolabs' or the 'Company,' Stock Code: 9887.HK) announced on March 6, 2026 that the ...

A plunge-style waterfall, the Abiqua Creek surges over moss-covered rocks before falling 92-feet down into a pool below.

Explore new findings on ovarian cancer and how blocking focal adhesion kinase can enhance immune response in treatment.